CuZn superoxide dismutase (CuZn SOD) is one of several antioxidant enz
ymes that defend the cell. against damage by oxygen free radicals. Mut
ations of the SOD1 gene encoding CuZn SOD are found in patients with f
amilial amyotrophic lateral sclerosis (FALS), a progressive and fatal
paralytic disease that is caused by the death of motor neurons in cort
ex, brainstem and spinal cord. The disease can be reproduced in transg
enic mice by expression of mutant human CuZn SOD. Recent studies both
in vitro and in vivo suggest that the effect of mutation is to enhance
the generation of oxygen radicals by the mutant enzyme. Thus, mutatio
n converts a protective, antioxidant enzyme into a destructive, prooxi
dant form that catalyses free radical damage to which motor neurons ar
e selectively vulnerable. Recent studies of neuroprotective agents in
the FALS model show that inhibition of oxidative mechanisms (copper ch
elation therapy, dietary antioxidants, and coexpression of bcl-2) dela
ys disease onset but does not extend disease duration. In contrast, in
hibition of glutamatergic or apoptotic mechanisms (riluzole, gabapenti
n, and coexpression of an inhibitor of caspase-1) has no effect on dis
ease onset but extends survival by increasing the duration of symptoma
tic disease. Thus, neuroprotective agents differentially target the pr
ocesses underlying disease initiation and propagation.